Literature DB >> 25666257

FLT3-ITD in acute promyelocytic leukemia: clinical distinct profile but still controversial prognosis.

Matteo Molica1, Massimo Breccia2.   

Abstract

Entities:  

Keywords:  Acute promyelocytic leukemia; FLT3; Prognosis

Mesh：

Substances：

Year:  2015        PMID： 25666257     DOI： 10.1016/j.leukres.2015.01.004

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  6 in total

1.  Prevalence and Clinical Significance of FLT3 and NPM1 Mutations in Acute Myeloid Leukaemia Patients of Assam, India.

Authors:  Jina Bhattacharyya; Sukanta Nath; Kandarpa Kumar Saikia; Renu Saxena; Sudha Sazawal; Manash Pratim Barman; Dushyant Kumar
Journal:  Indian J Hematol Blood Transfus       Date:  2017-04-28       Impact factor: 0.900

2.  PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy.

Authors:  L Cicconi; M Divona; C Ciardi; T Ottone; A Ferrantini; S Lavorgna; V Alfonso; F Paoloni; A Piciocchi; G Avvisati; F Ferrara; E Di Bona; F Albano; M Breccia; E Cerqui; M Sborgia; M G Kropp; A Santoro; A Levis; S Sica; S Amadori; M T Voso; F Mandelli; F Lo-Coco
Journal:  Leukemia       Date:  2016-05-02       Impact factor: 11.528

3.  High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based Regimen.

Authors:  Zeba N Singh; Vu H Duong; Rima Koka; Ying Zou; Sameer Sawhney; Li Tang; Maria R Baer; Nicholas Ambulos; Firas El Chaer; Ashkan Emadi
Journal:  J Hematop       Date:  2018-08-09       Impact factor: 0.196

4.  Potential Effects of the FLT3-ITD Mutation on Chemotherapy Response and Prognosis of Acute Promyelocytic Leukemia.

Authors:  Yu-Hua Song; Peng Peng; Chun Qiao; Jian-Yong Li; Qi-Qiang Long; Hua Lu
Journal:  Cancer Manag Res       Date:  2021-03-12       Impact factor: 3.989

5.  The Association of FLT3-ITD Gene Mutation with Bone Marrow Blast Cell Count, CD34, Cyclin D1, Bcl-xL and hENT1 Expression in Acute Myeloid Leukemia Patients.

Authors:  Paulus Budiono Notopuro; Jusak Nugraha; Budi Utomo; Harianto Notopuro
Journal:  Iran J Pathol       Date:  2020-07-16

Review 6.  Clinical use of FLT3 inhibitors in acute myeloid leukemia.

Authors:  Grerk Sutamtewagul; Carlos E Vigil
Journal:  Onco Targets Ther       Date:  2018-10-16       Impact factor: 4.147
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.